The effect of treating renal anemia The baseline values of Hb in the roxadustat and ESAs groups were 110.03 ± 1.71 g/L and 110.1 ± 1.52 g/L, respectively, with no significant difference between groups ( P = 0.974 ), and we observed an increasing trend in Hb in both groups over time.
← all excerpts
Roxadustat effectiveness versus ESAs in peritoneal dialysis patients during the COVID-19 pandemic: A retrospective study.
2
—
—
The sentences
The LVESD of patients in both roxadustat group and the ESAs group showed a decreasing trend over time, and significantly changed from baseline value to the 9th month (32.47 ± 0.62 mm vs. 35.68 ± 0.7 mm and 33.76 ± 0.38 mm vs. 35.5 ± 0.37 mm), with statistical significance ( P = 0.033 and P = 0.033 ), as shown in Fig 4C .